Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Androgen Receptor Antagonists [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
ENZALUTAMIDE 49,270 9,676 19.6% 9,282 576 76.0 yrs 0.6%
BICALUTAMIDE 4,061 462 11.4% 1,486 234 71.9 yrs 2.1%
CLASCOTERONE 1,099 0 N/A 2 2 31.3 yrs 89.8%
FLUTAMIDE 269 28 10.4% 54 6 66.9 yrs 9.5%
NILUTAMIDE 62 6 9.7% 9 1 77.1 yrs 0.0%

Head-to-Head Comparisons

ENZALUTAMIDE vs BICALUTAMIDE ENZALUTAMIDE vs CLASCOTERONE ENZALUTAMIDE vs FLUTAMIDE ENZALUTAMIDE vs NILUTAMIDE BICALUTAMIDE vs CLASCOTERONE BICALUTAMIDE vs FLUTAMIDE BICALUTAMIDE vs NILUTAMIDE CLASCOTERONE vs FLUTAMIDE CLASCOTERONE vs NILUTAMIDE FLUTAMIDE vs NILUTAMIDE
← Back to Androgen Receptor Antagonists [MoA] Class side effects →